Neurotrope Bioscience

Neurotrope is a biopharmaceutical and diagnostics company primarily focused on developing two product platforms: one is a diagnostic test for Alzheimer's disease, and the other is bryostatin, a drug candidate for the treatment of Alzheimer's disease. Both are currently in clinical testing stages.